Estrogen alone can cut risk of breast cancer
December 10th, 2010 - 12:52 pm ICT by ANIWashington, Dec 10 (ANI): A new study has suggested that hormone replacement therapy (HRT) utilizing estrogen alone helps in reducing breast cancer risk.
“Our analysis suggests that, contrary to previous thinking, there is substantial value in bringing HRT with estrogen alone to the guidelines. The data show that for selected women it is not only safe, but potentially beneficial for breast cancer, as well as for many other aspects of women’s health,” said lead researcher Joseph Ragaz of the University of British Columbia.
Ragaz and colleagues reviewed and reanalysed data from the Women’s Health Initiative (WHI) hormone replacement therapy trials.
“Over the last 30 years HRT has been used almost indiscriminately by women expecting the benefit of reducing cardiac risks, while providing a protective effect against bone fracture, and improving overall quality of life,” said Ragaz.
The WHI HRT trial consisted of two cohorts of women; the estrogen-alone group of women without a uterus and the estrogen-plus-progestin group of women with a uterus.
The team found that subsets of women with no strong family history of breast cancer who received estrogen alone had a significantly reduced breast cancer incidence.
In addition, the 75 percent of women without benign disease prior to the trial enrollment also had a reduced breast cancer risk.
“Reduction of rates of breast cancer in the majority of women who are candidates for estrogen-based HRT is a new finding because estrogen was always linked with a higher incidence of breast cancer,” said Ragaz.
The findings were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. (ANI)
- Breast cancer risk varies among different progestins used in hormone replacement therapy - Aug 11, 2010
- Hormone therapies 'up breast cancer metastasis risk in post-menopausal women' - May 07, 2010
- HRT raises risk of kidney stones - Oct 13, 2010
- How progesterone and estrogen increase breast cancer risk - Jan 19, 2011
- Low-carb diets better for easing weight: Study - Dec 13, 2011
- Hormone replacement therapy tied to breast cancer - Dec 30, 2011
- Breast cancer drug may reduce risk of death from lung cancer - Dec 12, 2009
- Menopausal hormone therapy 'ups ovarian cancer risk' - Nov 10, 2010
- Hormone therapy linked to increased breast cancer risk: Study - Aug 11, 2010
- Circulating tumour cells in blood up death risk in early-stage breast cancer patients - Dec 11, 2010
- Female sex hormone regulates weight - Oct 20, 2011
- Hormone replacement therapy 'increases lung cancer risk' - Mar 04, 2010
- How HRT and the Pill can lead to breast cancer - Sep 30, 2010
- Oestrogen therapy 'causes ovarian cancer to grow five times faster' - Oct 21, 2010
- Estrogen helps women pile on pounds - Oct 06, 2011
Tags: antonio breast cancer symposium, benign disease, bone fracture, breast cancer, breast cancer incidence, breast cancer risk, breast cancer symposium, cancer risk reduction, cardiac risks, health initiative, history of breast cancer, hormone replacement therapy, incidence of breast cancer, many other aspects, ragaz, san antonio breast, san antonio breast cancer, san antonio breast cancer symposium, trial enrollment, university of british columbia